PTCH codon 1315 polymorphism and risk for nonmelanoma skin cancer
- PMID: 15888139
- DOI: 10.1111/j.1365-2133.2005.06464.x
PTCH codon 1315 polymorphism and risk for nonmelanoma skin cancer
Abstract
Background: The PTCH tumour suppressor gene is involved in the development of nearly all basal cell carcinomas (BCCs) of the skin and a fraction of squamous cell carcinomas (SCCs). A nonconservative Pro/Leu nucleotide polymorphism within PTCH exon 23 at codon 1315 was recently reported to be potentially important for the development of breast epithelial cell cancers. Objectives Accordingly, the status of PTCH codon 1315 was analysed for a possible association with the development of nonmelanoma skin cancers (NMSCs) in a pilot study. Because skin cancer risk is affected by specific population-dependent phenotypes such as skin and hair colour, codon 1315 was also analysed for normal allele frequency variation in human populations having differing extents of eumelanin vs. phaeomelanin.
Methods: The single nucleotide polymorphism in codon 1315 of the human PTCH gene was analysed in genomic DNA from six different populations comprising 472 blood samples and from 170 patients in four different categories with NMSC. Polymerase chain reaction and pyrosequencing were used to determine the allele frequencies. Allelic loss was furthermore determined in tumours following microdissection.
Results: The Pro/Pro genotype frequency ranged from 30% to 65% between populations, with a significant trend for a reduced frequency of the Pro/Pro genotype in populations having lighter pigmentation (P = 0.020). Pro/Pro frequency showed an increasing trend with increasing tumour case severity (P = 0.027). In 260 samples from 180 Swedish patients with NMSC and a control group of 96 healthy ethnically matched volunteers, no statistically significant pairwise differences between groups were detected in the PTCH codon 1315 allelic distribution, neither was a difference seen for multiple or early onset cases of BCC in the Swedish population. In Swedish patients with single tumours, allelic loss (loss of heterozygosity) was observed in 20 of 30 (67%) patients with BCC and four of 22 (18%) patients with SCC, with no preference in the allele lost. In contrast, the Pro/Pro genotype was frequent in seven U.S. patients having multiple independent BCCs. One of these patients was heterozygous, enabling allelic loss studies. Of 20 independent tumours, 11 had lost an allele; 10 of the 11 had lost Leu, suggesting nonrandom loss that favoured retention of Pro (P = 0.0059).
Conclusions: Our results indicate an association between the eumelanin-to-phaeomelanin shift and a shift from the Pro/Pro genotype to Leu-containing genotypes. Failure to lose Pro during the shift to phaeomelanin may be associated with an increased population risk for BCC and increased individual risk for multiple BCC. During development of a tumour, the effect of Pro may be magnified by loss of the Leu allele.
Similar articles
-
Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas.Br J Dermatol. 2005 Jan;152(1):43-51. doi: 10.1111/j.1365-2133.2005.06353.x. Br J Dermatol. 2005. PMID: 15656799
-
Allelic loss at Drosophila patched gene is highly prevalent in Basal and squamous cell carcinomas of the skin.J Invest Dermatol. 2006 May;126(5):1152-8. doi: 10.1038/sj.jid.5700209. J Invest Dermatol. 2006. PMID: 16484983
-
Interaction between p53 codon 72 polymorphism and melanocortin 1 receptor variants on suntan response and cutaneous melanoma risk.Br J Dermatol. 2008 Aug;159(2):314-21. doi: 10.1111/j.1365-2133.2008.08624.x. Epub 2008 May 28. Br J Dermatol. 2008. PMID: 18510673 Free PMC article.
-
Carcinogenesis of basal cell carcinomas: genetics and molecular mechanisms.Br J Dermatol. 2002 Apr;146 Suppl 61:17-9. doi: 10.1046/j.1365-2133.146.s61.5.x. Br J Dermatol. 2002. PMID: 11966727 Review.
-
Molecular biology of basal and squamous cell carcinomas.Adv Exp Med Biol. 2014;810:234-52. doi: 10.1007/978-1-4939-0437-2_13. Adv Exp Med Biol. 2014. PMID: 25207369 Review.
Cited by
-
PTCH1 Gene Variants, mRNA Expression, and Bioinformatics Insights in Mexican Cutaneous Squamous Cell Carcinoma Patients.Biology (Basel). 2024 Mar 16;13(3):191. doi: 10.3390/biology13030191. Biology (Basel). 2024. PMID: 38534460 Free PMC article.
-
PTCH1 gene variants rs357564, rs2236405, rs2297086 and rs41313327, mRNA and tissue expression in basal cell carcinoma patients from Western Mexico.J Clin Lab Anal. 2024 Feb;38(3):e25010. doi: 10.1002/jcla.25010. Epub 2024 Jan 29. J Clin Lab Anal. 2024. PMID: 38287479 Free PMC article.
-
Mutational analysis of hedgehog signaling pathway genes in human malignant mesothelioma.PLoS One. 2013 Jun 24;8(6):e66685. doi: 10.1371/journal.pone.0066685. Print 2013. PLoS One. 2013. PMID: 23826113 Free PMC article.
-
Mutations in the hedgehog pathway genes SMO and PTCH1 in human gastric tumors.PLoS One. 2013;8(1):e54415. doi: 10.1371/journal.pone.0054415. Epub 2013 Jan 18. PLoS One. 2013. PMID: 23349881 Free PMC article.
-
A population-based study of hedgehog pathway gene variants in relation to the dual risk of basal cell carcinoma plus another cancer.Cancer Epidemiol. 2012 Oct;36(5):e288-93. doi: 10.1016/j.canep.2012.05.001. Epub 2012 Jun 5. Cancer Epidemiol. 2012. PMID: 22677152 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials